Clinical Trial Detail

NCT ID NCT03709576
Title Pevonedistat and Azacitidine as Maintenance Therapy After Allogeneic Stem Cell Transplantation for Non-Remission AML
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

acute myeloid leukemia

Therapies

Azacitidine + MLN4924

Age Groups: senior adult

No variant requirements are available.